Hardman Johnston Global Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-935,713
Closed -$192M 74
2017
Q3
$192M Buy
935,713
+13,077
+1% +$3.04M 8.18% 4
2017
Q2
$224M Buy
922,636
+154,530
+20% +$36.3M 9.68% 2
2017
Q1
$184M Buy
768,106
+3,415
+0.4% +$795K 8.25% 2
2016
Q4
$161M Buy
764,691
+41,540
+6% +$8.61M 7.83% 3
2016
Q3
$167M Buy
723,151
+142,557
+25% +$34.8M 7.58% 3
2016
Q2
$134M Buy
+580,594
New +$134M 6.83% 3

Other funds holding AGN

Hardman Johnston Global Advisors's AGN Position: Q4 2017 in Review

Hardman Johnston Global Advisors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 935,713 shares — an estimated $192M sold.

Hardman Johnston Global Advisors first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $224M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Hardman Johnston Global Advisors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 935,713 Allergan plc shares in Q4 2017, an estimated $192M.
  • Hardman Johnston Global Advisors first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Hardman Johnston Global Advisors's Allergan plc position peaked at $224M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Hardman Johnston Global Advisors's 13F filing for Q4 2017, filed 26 Jan 2018.